Recently in Defective Drugs Category

Actos and Increased Risk of Bladder Cancer

June 20, 2011, by

The FDA recently reported that people taking Actos (pioglitazone) for more than a year have an increased risk of bladder cancer. Two European countries have already banned the drug.

Talk with your doctor if you are taking Actos.